https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-28 / World J. Gastroenterol. 2008 Jan;14(4):532-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-28 / World J. Gastroenterol. 2008 Jan;14(4):532-402008-01-28 00:00:002019-02-15 08:38:06An effective vaccine against colon cancer in mice: use of recombinant adenovirus interleukin-12 transduced dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-25 / J Transl Med 2008 Jan;6:6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-25 / J Transl Med 2008 Jan;6:62008-01-25 00:00:002019-02-15 09:19:34A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-23 / Ann. Surg. Oncol. 2008 Jun;15(6):1807
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-23 / Ann. Surg. Oncol. 2008 Jun;15(6):18072008-01-23 00:00:002019-02-15 09:19:29Dendritic cells in patients with melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-22 / Exp. Hematol. 2008 Mar;36(3):329-39
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-22 / Exp. Hematol. 2008 Mar;36(3):329-392008-01-22 00:00:002019-02-15 08:32:33Efficient monocyte-derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: application to active immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-18 / Genet Vaccines Ther 2008 Jan;6:2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-18 / Genet Vaccines Ther 2008 Jan;6:22008-01-18 00:00:002019-02-15 09:24:02Therapeutic dendritic cell vaccine preparation using tumor RNA transfection: a promising approach for the treatment of prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-17 / Gene Ther. 2008 Mar;15(5):371-83
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-17 / Gene Ther. 2008 Mar;15(5):371-832008-01-17 00:00:002019-02-15 09:22:05Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-15 / Transfusion 2008 May;48(5):861-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-15 / Transfusion 2008 May;48(5):861-702008-01-15 00:00:002019-02-15 08:32:31Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-14 / Urol. Oncol. 2009 Jan-Feb;27(1):26-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-14 / Urol. Oncol. 2009 Jan-Feb;27(1):26-322008-01-14 00:00:002019-02-15 09:23:59Dendritic cells transduced with a PSMA-encoding adenovirus and cocultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against prostate cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-10 / J. Viral Hepat. 2008 Mar;15(3):219-28
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-10 / J. Viral Hepat. 2008 Mar;15(3):219-282008-01-10 00:00:002019-02-15 08:37:35Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-01 / Cancer Ther 2008;6(B):955-964
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-01 / Cancer Ther 2008;6(B):955-9642008-01-01 00:00:002019-02-15 08:52:42A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors
